$1,000 invested Gilead Sciences Inc. (2016)
NASDAQ · GILD · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-10-15
Today you would have
$2,297
+$1,297 (+129.69%)
GILDSPY (benchmark)
- Entry price
- $68.52
- Current price
- $157.37
- Shares
- 14.5952
- CAGR
- +8.02%
- Max Drawdown
- -36.01%
- vs SPY
- -224.55 pp
✦The story
A $1,000 investment in Gilead Sciences in early 2016 reached $2,297 by mid-2026, up +129.7%. The entry came near the peak of the company's hepatitis C drug sales, and revenue declines in the following years kept the stock subdued for a long stretch. The S&P 500 returned +354.2% over the same decade, far ahead of Gilead.
#Related scenariosfor comparison
Other years for GILD